These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24915177)

  • 1. A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination.
    Rudolf AF; Skovgaard T; Knapp S; Jensen LJ; Berthelsen J
    PLoS One; 2014; 9(6):e98800. PubMed ID: 24915177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors.
    Puhl-Rubio AC; Stashko MA; Wang H; Hardy PB; Tyagi V; Li B; Wang X; Kireev D; Jessen HJ; Frye SV; Shears SB; Pearce KH
    SLAS Discov; 2018 Oct; 23(9):982-988. PubMed ID: 29842835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors paradoxically prime kinases.
    Frye SV; Johnson GL
    Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
    Simard JR; Rauh D
    Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Affinity and Residence Time of Potent Drug-Target Complexes by Label-free Biosensing.
    Quinn JG; Pitts KE; Steffek M; Mulvihill MM
    J Med Chem; 2018 Jun; 61(12):5154-5161. PubMed ID: 29772180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery.
    Slon-Usakiewicz JJ; Dai JR; Ng W; Foster JE; Deretey E; Toledo-Sherman L; Redden PR; Pasternak A; Reid N
    Anal Chem; 2005 Mar; 77(5):1268-74. PubMed ID: 15732906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
    Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
    Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain.
    Kim DJ; Choi CK; Lee CS; Park MH; Tian X; Kim ND; Lee KI; Choi JK; Ahn JH; Shin EY; Shin I; Kim EG
    Exp Mol Med; 2016 Apr; 48(4):e229. PubMed ID: 27126178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
    Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
    Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual target screening: validation using kinase inhibitors.
    Santiago DN; Pevzner Y; Durand AA; Tran M; Scheerer RR; Daniel K; Sung SS; Woodcock HL; Guida WC; Brooks WH
    J Chem Inf Model; 2012 Aug; 52(8):2192-203. PubMed ID: 22747098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule discrimination map of the antibiotic resistance kinome.
    Shakya T; Stogios PJ; Waglechner N; Evdokimova E; Ejim L; Blanchard JE; McArthur AG; Savchenko A; Wright GD
    Chem Biol; 2011 Dec; 18(12):1591-601. PubMed ID: 22195561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust and quantitative assay platform for multiplexed, high throughput screening of protein kinase inhibitors.
    Lee J; Park IS; Park G; Cho K; Park HS; Min DH
    Chem Commun (Camb); 2016 Oct; 52(81):12112-12115. PubMed ID: 27709210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations.
    Simard JR; Rauh D
    Methods Enzymol; 2014; 548():147-71. PubMed ID: 25399645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery and the human kinome: recent trends.
    Eglen R; Reisine T
    Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
    Fischer PM
    Med Res Rev; 2017 Mar; 37(2):314-367. PubMed ID: 27775829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.
    Deacon SW; Beeser A; Fukui JA; Rennefahrt UE; Myers C; Chernoff J; Peterson JR
    Chem Biol; 2008 Apr; 15(4):322-31. PubMed ID: 18420139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.